The Egyptian Myeloproliferative Neoplasms Study Group: A Stepping Stone Toward Establishing a National Hematologic Malignancies Network (SOHO 2026) - Sep 1, 2026 - Abstract #MPN-1109; Location: LEVEL 3, HALL B3; "Registry data contributed to supporting ruxolitinib approval under the national insurance umbrella... The Egyptian MPN Study Group demonstrated the feasibility and impact of a multicenter hematologic malignancy database in Egypt. By integrating patient-centered assessment, longitudinal follow-up, researcher engagement, and evidence that guides policy-makers, the MPN registry improved understanding of MPN in Egypt. More importantly, it paved the way for broader hematologic malignancy databases, a critical step toward establishing a national hematologic malignancies network in Egypt."
Hematological Malignancies • Leukemia • Multiple Myeloma • Myelofibrosis • Myeloproliferative Neoplasm • Oncology • Polycythemia Vera
|
|
Ayman Youssef MBBCh 1,2; Mohamed Elbahoty MBBCh,PhD 2,3; Reem Eshra MBBCh 2; Nooran Soror MBBCh 2; Mona Elgamal 2; Ashraf Elghandour MBBCh,PhD 2
|